Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
Open Access
- 31 August 2012
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 176 (6), 527-533
- https://doi.org/10.1093/aje/kws313
Abstract
Although vaccination against influenza is recommended for elderly and high-risk patients in many countries, efficacy in the elderly has been suboptimal. The MF59 adjuvanted trivalent inactivated vaccine (ATIV) was developed to increase the immune response of elderly subjects to influenza vaccination, but its effectiveness has not yet been well documented. This prospective, observational study evaluated the relative effectiveness of ATIV versus nonadjuvanted trivalent inactivated vaccine (TIV) in individuals at least 65 years of age in Lombardy, northern Italy. Hospitalizations for influenza or pneumonia (International Classification of Diseases, Ninth Revision, Clinical Modification, codes 480–487) during the 2006–2007, 2007–2008, and 2008–2009 influenza seasons were identified from administrative databases. Stratified and regression analyses, including the propensity score to adjust for confounding, as well as generalized estimating equations to account for repeated vaccination, were used. Overall, 107,661 records were evaluated, contributing 170,988 person-seasons of observation. Since ATIV is preferentially recommended for more frail individuals, subjects vaccinated with ATIV were older and had more functional impairment and comorbidities. In the primary analysis, risk of hospitalization for influenza or pneumonia was 25% lower for ATIV relative to TIV (relative risk = 0.75, 95% confidence interval: 0.57, 0.98). To the extent that there is residual bias, ATIV is likely to be even more protective than this result suggests.Keywords
This publication has 29 references indexed in Scilit:
- Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation StudyAmerican Journal of Epidemiology, 2010
- Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversyVaccine, 2009
- New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniorsJournal of Clinical Epidemiology, 2009
- Issues concerning the use of hormone replacement therapy and risk of fracture: a population‐based, nested case‐control studyBritish Journal of Clinical Pharmacology, 2007
- Variable Selection for Propensity Score ModelsAmerican Journal of Epidemiology, 2006
- A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methodsJournal of Clinical Epidemiology, 2005
- Immunogenicity and protective efficacy of influenza vaccinationVirus Research, 2004
- The iatrogenic costs of NSAID therapy: A population studyArthritis & Rheumatism, 2002
- Multiple Imputation after 18+ YearsJournal of the American Statistical Association, 1996
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986